Skip to content
Northway Biotech logo — Biologics CDMO located in Waltham, MA, and Vilnius, Lithuani...

Northway Biotech

Biologics CDMO located in Waltham, MA, and Vilnius, Lithuania

Founded 2004 Lithuania Lithuania 160 employees Total: $630.00K Biotechnology

General Information

Company Name Northway Biotech
Founded Year 2004
Location Lithuania Lithuania
Employees 160
Industries Biotechnology
Business Model B2B, D2C, White Label
Revenue Model Service Fee, Project Based, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Northway Biotech. To contact Northway Biotech, visit northwaybiotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Northway Biotech compare?

A PDF of Northway Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Northway Biotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Northway Biotech

Northway Biotech, a Biotechnology firm established in 2004, operates as a Contract Development and Manufacturing Organization (CDMO) with facilities in Waltham, MA, and Vilnius, Lithuania. Known for their comprehensive services, they manage the biopharmaceutical value chain extensively, from gene development to drug production within microbial and mammalian expression systems.

Northway Biotech boasts a strong capability in adjusting to project dynamics with their rapid response to changes, offering flexibility and an ability to scale capabilities. Their end-to-end offerings encompass critical elements like Cell Line Development, cGMP Manufacturing of biologics and biosimilars, Quality Assurance, and Regulatory CMC Support.

The company last received a €310.00K grant from the Eurostars SME programme on 01 July 2015. Investors seeking to engage with a nimble, scientifically robust, and geographically diverse CDMO with well-established industry expertise may find Northway Biotech an attractive prospect.

Business keywords: Biologics CDMO, Mammalian Cell Line Development, Microbial Cell Line Development, Analytical Methods Development, Formulation Development, Upstream Process Development, Downstream Process Development, cGMP Manufacturing, Biopharmaceuticals, Biosimilars, pDNA Manufacturing, Fill & Finish, Regulatory CMC Support, Drug Substance & Drug Product Manufacturing

Services & Products

Cell Line Development
Process Development (USP & DSP)
Analytical Methods Development
Formulation Development
Viral Clearance Studies
cGMP Manufacturing of Drug Substance and Drug Product
Quality Assurance and Quality Control

Target Customers

Biopharmaceutical Companies Research Institutions Vaccine Developers Biotech Startups

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €310.00K 1
Eurostars SME programme
01 Jul 2015
Grant €320.00K 1
Eurostars SME programme
01 Apr 2015

Northway Biotech Alternatives & Competitors

View All Alternatives
Northway Biotech vs
AGC Biologics
AGC Biologics United States

We work side by side with our customers to improve patients’ lives by bringing new biopharmaceutical...

Venture round
2531 employees
Biotechnology, Industrial
Northway Biotech vs

Your premier CDMO for biologics drug development and manufacturing, from early development, to IND,...

Series B
73 employees
Biopharma, Biotechnology
Northway Biotech vs
Wheeler Bio, Inc.
Wheeler Bio, Inc. United States

CMC Made for Biotechs

Series A
76 employees
Biotechnology, Health and Wellness

FAQ About Northway Biotech

Biologics CDMO located in Waltham, MA, and Vilnius, Lithuania
Northway Biotech was founded in 2004.
Northway Biotech is headquartered in Lithuania.
Northway Biotech operates in Biotechnology. Its work centres on Biologics CDMO, Mammalian Cell Line Development, Microbial Cell Line Development and Analytical Methods Development. Its customers include Biopharmaceutical Companies, Research Institutions and Vaccine Developers.
Northway Biotech has a B2B, D2C and White Label business model. Its revenue comes from Service Fee, Project Based and Usage Based.
Northway Biotech has approximately 160 employees.
Northway Biotech has completed 2 funding rounds, raising a total of $630.00K.
Northway Biotech offers: Cell Line Development, Process Development (USP & DSP), Analytical Methods Development, Formulation Development, Viral Clearance Studies, cGMP Manufacturing of Drug Substance and Drug Product, Quality Assurance and Quality Control.
Top alternatives and competitors to Northway Biotech include AGC Biologics, JOINN Biologics US Inc., Wheeler Bio, Inc., Cytovance Biologics, 53Biologics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Northway Biotech and AGC Biologics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Northway Biotech, https://bouncewatch.com/company/northway-biotech, updated 2 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout